Results 31 to 40 of about 7,722 (240)

Rescue of Mitochondrial Function in Hutchinson-Gilford Progeria Syndrome by the Pharmacological Modulation of Exportin CRM1

open access: yesCells, 2023
Hutchinson-Gilford progeria syndrome (HGPS) is a rare premature aging disorder caused by the expression of progerin, a mutant variant of Lamin A. Recently, HGPS studies have gained relevance because unraveling its underlying mechanism would help to ...
Feliciano Monterrubio-Ledezma   +6 more
doaj   +1 more source

Arterial stiffness and cardiac dysfunction in Hutchinson–Gilford Progeria Syndrome corrected by inhibition of lysyl oxidase

open access: yesLife Science Alliance, 2021
The findings show that increased lysyl oxidase abundance is causal for the elevated arterial stiffness present in the arteries of Hutchinson–Gilford Progeria Syndrome mice.
Ryan von Kleeck   +8 more
doaj   +1 more source

Loss of H3K9me3 correlates with impaired ATM activation in HGPS. [PDF]

open access: yes, 2016
(A). Representative fluorescence images of gammaH2AX and H3K9me3 in middle passage normal and HGPS fibroblasts after Dox treatment. “Low H3K9me3” is defined as any H3K9me3 fluorescence intensity that falls below the lower 5% of the normal population ...
Celeste Witting (3372776)   +6 more
core   +1 more source

Sim-Ptychography Imaging of Hutchinson-Gilford Progeria Syndrome (HGPS) Cells [PDF]

open access: yes, 2021
180a Wednesday, February 24, 2021 ptychographic module was developed and mounted on a commercial SIM, to simultaneously collect ptychography and SIM data.
Cainero, Isotta   +3 more
core   +1 more source

HGPS fibroblasts show reduced gammaH2AX response upon Dox treatment. [PDF]

open access: yes, 2016
(A) Representative fluorescence images of gammaH2AX foci in middle passage normal and HGPS fibroblasts after Dox treatment. Scale Bar: 5um. (B).
Celeste Witting (3372776)   +6 more
core   +1 more source

Molecular and Cellular Mechanisms Driving Cardiovascular Disease in Hutchinson-Gilford Progeria Syndrome: Lessons Learned from Animal Models

open access: yesCells, 2021
Hutchinson-Gilford progeria syndrome (HGPS) is a rare genetic disease that recapitulates many symptoms of physiological aging and precipitates death. Patients develop severe vascular alterations, mainly massive vascular smooth muscle cell loss, vessel ...
Ignacio Benedicto   +2 more
doaj   +1 more source

Disrupting the LINC Complex in Smooth Muscle Cells Reduces Aortic Disease in a Mouse Model of HGPS

open access: yesScience Translational Medicine, 2018
Disrupting the LINC complex reduces aortic disease in a mouse model of Hutchinson-Gilford progeria syndrome. Help for HGPS Children with Hutchinson-Gilford progeria syndrome (HGPS), a rare disorder of accelerated aging caused by mutations in lamin ...
Paul H. Kim   +12 more
semanticscholar   +1 more source

In Vivo Base Editing Rescues Hutchinson-Gilford Progeria Syndrome in Mice

open access: yesNature, 2021
Hutchinson–Gilford progeria syndrome (HGPS or progeria) is typically caused by a dominant-negative C•G-to-T•A mutation (c.1824 C>T; p.G608G) in LMNA, the gene that encodes nuclear lamin A.
Luke W. Koblan   +20 more
semanticscholar   +1 more source

Temsirolimus does not impact HGPS mitochondrial dysfunction. [PDF]

open access: yes, 2016
(A) Immunohistochemistry was performed on mock-treated or temsirolimus-treated control (GMO3349C) and HGPS (HGADFN003) fibroblasts (9 days of treatment). Antibodies against NADPH oxidase subunit 4 (Nox4) and progerin were used.
Diana Gabriel (3608093)   +2 more
core   +1 more source

Methylene blue restores H3K9me3 and rescues DDR defects in HGPS. [PDF]

open access: yes, 2016
(A). Western blotting analysis with anti-pATM(S1981), anti-ATM, anti- gammaH2AX, anti-HP1alpha, anti-H3K9me3 and anti-GAPDH antibodies on late passage normal and HGPS fibroblasts treated with or without MB after 30 days.
Celeste Witting (3372776)   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy